StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) income statement

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Impact BioMedical Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
-1120.0%
Operating margin
-14597.1%
Net margin
2254.3%
Return on equity, FY2025
-142.9%

Financial strength

Current ratio
0.16
Debt to equity
–
Debt to assets
–
Cash to current liabilities
0.5%

Valuation

P/E ratio
–
Price to sales
9426.66
Price to book
30.65
Dividend yield
–

See a number that looks wrong?